Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -206,470 | -136,061 | -111,399 | -21,226 | -171,961 |
| Depreciation Amortization | 20,225 | 9,880 | 32,792 | 29,042 | 17,567 |
| Accounts receivable | -3,286 | -1,547 | -11,264 | -3,295 | -4,080 |
| Accounts payable and accrued liabilities | -15,641 | -24,841 | 24,763 | 7,468 | 3,311 |
| Other Working Capital | -63,683 | -2,946 | -25,475 | -32,576 | -27,681 |
| Other Operating Activity | 109,607 | 36,510 | -189,438 | -188,961 | 32,430 |
| Operating Cash Flow | $-159,248 | $-119,005 | $-280,021 | $-209,548 | $-150,414 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 216,967 | 111,364 | -109,367 | -96,719 | -28,789 |
| PPE Investments | -82 | N/A | N/A | -643 | -633 |
| Purchase Sale Intangibles | -18,377 | -6,466 | -41,591 | -36,086 | -31,170 |
| Other Investing Activity | -83,377 | -6,466 | 165,143 | 170,088 | -31,170 |
| Investing Cash Flow | $133,508 | $104,898 | $55,776 | $72,726 | $-60,592 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 0 | 219,068 | 219,068 | 218,917 |
| Other Financing Activity | 257 | -525 | -316 | -440 | 345 |
| Financing Cash Flow | $257 | $-525 | $218,752 | $218,628 | $219,262 |
| Exchange Rate Effect | -402 | -293 | 1,981 | 750 | 930 |
| Beginning Cash Position | 58,176 | 58,176 | 61,688 | 61,688 | 61,688 |
| End Cash Position | 32,291 | 43,251 | 58,176 | 144,244 | 70,874 |
| Net Cash Flow | $-25,885 | $-14,925 | $-3,512 | $82,556 | $9,186 |
| Free Cash Flow | |||||
| Operating Cash Flow | -159,248 | -119,005 | -280,021 | -209,548 | -150,414 |
| Capital Expenditure | -82 | N/A | N/A | -643 | -633 |
| Free Cash Flow | -159,330 | -119,005 | -280,021 | -210,191 | -151,047 |